ECTRIMS supports and communicates advances in MS treatment through a variety of activities and collaborations. A key goal of our mission is to be actively involved in coordinating initiatives in research and clinical care in Europe and worldwide.
The Clinical Guideline on the Pharmacological Treatment of People With Multiple Sclerosis was developed jointly by ECTRIMS and the European Academy of Neurology (EAN).
A number of governmental not-for-profit and for-profit organisations provide useful and easily accessible registries for recent and ongoing clinical trials.
Clinicaltrials.gov is a registry of worldwide clinical trials run by the United States Library of Medicine.
The Multiple Sclerosis International Federation (MSIF) provides a list of MS databases and registries in Europe and Australia and general information about clinical trial design for patients interested in participating in a study.